Mucin derived polypeptides

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9119869
APP PUB NO 20120028911A1
SERIAL NO

13097680

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Isolated MUC17, Muc3 or MUC3 derived polypeptides and polynucleotides encoding the same are described. The MUC17, Muc3 or MUC3 derived polypeptides, polynucleotides, and pharmaceutical compositions can be used to treat gastrointestinal tract diseases and disorders including, inflammatory bowel disease and its associated colitides, for example, Crohn's Disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MUCIMED INC350 EAST MICHIGAN AVENUE SUITE 500 KALAMAZOO MI 49007-3800

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Heinrikson, Robert L Plainwell, US 36 325
Ho, Samuel B San Diego, US 5 8
Shebuski, Ronald J Alexandria, US 8 108
Shekels, Laurie Orono, US 2 6

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 1, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00